Monitoring Salivary Gland Health After Radiation for Nasopharyngeal Cancer
Part of Cancer, Ear, nose & throat clinical trials.
This trial uses advanced imaging (MRI scans) to see how radiation therapy affects the salivary glands in people being treated for nasopharyngeal cancer. The goal is to find better ways to prevent or manage dry mouth and other side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with nasopharyngeal cancer (a type of throat cancer).
- You are scheduled to receive radiation therapy as part of your treatment.
- You are 18 years old or older.
- You are able to have an MRI scan (no metal implants, no severe claustrophobia).
- You agree to sign a consent form.
- You are not pregnant or breastfeeding, and you do not have severe kidney or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a new radiation technique designed to reduce dry mouth (xerostomia) with standard radiation for people with nasopharyngeal cancer. It aims to see if the new approach can protect saliva glands while still treating the cancer effectively.
This study uses special MRI scans to monitor how the parotid gland (a saliva gland near the jaw) is affected by radiation therapy for nasopharyngeal cancer. The goal is to better understand and possibly reduce side effects like dry mouth.
This trial tests if using an MRI to map saliva glands before radiation can help spare them, reducing dry mouth. It is for people with oropharynx cancer who will receive radiation with or without chemotherapy.
This trial compares two treatments—a salivary gland procedure (sialendoscopy) and a light therapy (photobiomodulation)—to prevent dry mouth caused by radiation therapy for head and neck cancer. If you are about to start radiation and meet the dose limits, you may be eligible.
This study uses special MRI images (and computer “radiomics” scores) to better understand nasopharyngeal cancer. The goal is to help doctors choose the most appropriate treatment for people with newly diagnosed cancer.
This study is looking for proteins or other substances in the blood (biomarkers) that can help predict how well head and neck cancer patients respond to radiation therapy. If you have head and neck cancer and are scheduled for radiation, possibly with chemo, immunotherapy, or targeted therapy, you may be able to join.
Hear when a new Nasopharyngeal Carcinoma ,Xerostomia,Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.